Related Experiment Video
Updated: Sep 2, 2025

Experimental Human Pneumococcal Carriage
Published on: February 15, 2013
Pneumococcal vaccination coverage and willingness in mainland China
Weihao Shao1, Xiaorui Chen1, Caifang Zheng1
1Department of Epidemiology, School of Public Health, Zhengzhou University, Zhengzhou, China.
Pneumococcal vaccination coverage and willingness in China are low. Factors like doctor recommendations and prior vaccination history increase willingness, highlighting areas for public health improvement.
Area of Science:
- Public Health
- Epidemiology
- Vaccinology
Background:
- Pneumococcal vaccination is crucial for preventing pneumonia, especially in vulnerable populations.
- Understanding vaccination coverage and willingness is essential for targeted public health interventions in China.
Purpose of the Study:
- To estimate the current pneumococcal vaccination coverage and willingness among people in mainland China.
- To identify key factors influencing the willingness to receive pneumococcal vaccination.
Main Methods:
- A systematic literature search was conducted across English and Chinese databases up to October 2021.
- Random-effects meta-analysis was employed to synthesize data from 97 included studies.
- Subgroup analysis and meta-regression explored heterogeneity in coverage and willingness.
Main Results:
- Overall pneumococcal vaccination coverage was 21.7%, with variations across regions and resident types (permanent vs. floating).
- Vaccination willingness was estimated at 51.2%, higher in urban areas and among parents and those with a pneumonia history.
- Factors positively associated with willingness included recommendations from family/physicians, previous vaccinations, and perceived vaccine effectiveness.
Conclusions:
- Pneumococcal vaccination coverage and willingness in mainland China are lower compared to global benchmarks.
- Public health strategies should leverage physician recommendations, patient history, and education on vaccine effectiveness to enhance uptake.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
06:32Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
Related Concept Videos
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia III: Complications and Assessment
Vaccinations
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: